Trial · NCT01013532
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
NCT01013532, Phase 4, Unknown, Asan Medical Center
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage. Trials, record NCT01013532. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01013532
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
- NCT number
- NCT01013532
- Status
- Unknown
- Phases
- Phase 4
- Enrollment
- 1,600 participants, estimated
- Lead sponsor
- Asan Medical Center
- Conditions
- Brain Ischemia, Intracranial Hemorrhages
- Interventions
Cilostazol, Probucol, Aspirin, placebo of cilostazol, placebo of aspirin, ankle-brachial index (ABI), intima-medial thickness (IMT), new asymptomatic brain hemorrhage, new ischemic lesions on follow-up FLAIR images
- First posted
- 2009-11-13
- Last updated
- 2015-12-24
Source ClinicalTrials.gov
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Time to the first occurrence of cerebral hemorrhage | time since randomization; follow-up period is 1.0 to 5.5 years | |
| Primary | Time to the first occurence of composite cardiovascular events | time since randomization; follow-up period is 1.0 to 5.5 years | |
| Secondary | Time to the first occurrence of stroke | time since randomization; follow-up period is 1.0 to 5.5 years | |
| Secondary | Time to the first occurrence of ischemic stroke | time since randomization; follow-up period is 1.0 to 5.5 years | |
| Secondary | Time to the first occurence of myocardial infarction | time since randomization; follow-up period is 1.0 to 5.5 years | |
| Secondary | Time to the first occurence of other designated vascular events | time since randomization; follow-up period is 1.0 to 5.5 years | |
| Other | Incidence rate of major and non-major hemorrhagic event | time since randomization; follow-up period is 1.0 to 5.5 years | |
| Other | Rate of asymptomatic hemorrhage in GRE (microhemorrhage or macrohemorrhage) | at final visit, follow-up MRI will be checked at the final visit | |
| Other | Rate of new asymptomatic cerebral infarction lesion in FLAIR | at final visit, follow-up MRI will be checked at the final visit | |
| Other | Change of ankle-brachial index | at final visit;follow-up period is 1.0 to 5.5 years |
1 to 10 of 13Source ClinicalTrials.gov
See all 13 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers8
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01013532
GET https://conductscience.org/api/trials/v1/NCT01013532/registered